Literature DB >> 15368573

Inhibition of Golgi mannosidase II with mannostatin A analogues: synthesis, biological evaluation, and structure-activity relationship studies.

Bing Li1, Sameer P Kawatkar, Shaji George, Heather Strachan, Robert J Woods, Aloysius Siriwardena, Kelley W Moremen, Geert-Jan Boons.   

Abstract

Mannostatin and aminocyclopentitetrol analogues with various substitutions at the amino function were synthesized. These compounds were tested as inhibitors of human Golgi and lysosomal alpha-mannosidases. Modification of the amine of mannostatin had only marginal effects, whereas similar modifications of aminocyclopentitetrol led to significantly improved inhibitors. Ab initio calculations and molecular docking studies were employed to rationalize the results. It was found that mannostatin and aminocyclopentitretrol could bind to Golgi alpha-mannosidase II in a similar mode to that of the known inhibitor swainsonine. However, due to the flexibility of the five-membered rings of these compounds, additional low-energy binding modes could be adopted. These binding modes may be relevant for the improved activities of the benzyl-substituted compounds. The thiomethyl moiety of mannostatin was predicted to make favorable hydrophobic interactions with Arg228 and Tyr727 that would possibly account for its greater inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368573     DOI: 10.1002/cbic.200300842

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Characterization of a human core-specific lysosomal {alpha}1,6-mannosidase involved in N-glycan catabolism.

Authors:  Chaeho Park; Lu Meng; Leslie H Stanton; Robert E Collins; Steven W Mast; Xiaobing Yi; Heather Strachan; Kelley W Moremen
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Characterisation of class I and II α-mannosidases from Drosophila melanogaster.

Authors:  Ivana Nemčovičová; Sergej Šesták; Dubravko Rendić; Margita Plšková; Ján Mucha; Iain B H Wilson
Journal:  Glycoconj J       Date:  2013-08-25       Impact factor: 2.916

3.  Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions.

Authors:  Sameer P Kawatkar; Douglas A Kuntz; Robert J Woods; David R Rose; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2006-06-28       Impact factor: 15.419

4.  The molecular basis of inhibition of Golgi alpha-mannosidase II by mannostatin A.

Authors:  Douglas A Kuntz; Wei Zhong; Jun Guo; David R Rose; Geert-Jan Boons
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

5.  Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant.

Authors:  Wei Zhong; Douglas A Kuntz; Brian Ember; Harminder Singh; Kelley W Moremen; David R Rose; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2008-06-18       Impact factor: 15.419

6.  N-Benzyl Substitution of Polyhydroxypyrrolidines: The Way to Selective Inhibitors of Golgi α-Mannosidase II.

Authors:  Sergej Šesták; Maroš Bella; Tomáš Klunda; Soňa Gurská; Petr Džubák; Florian Wöls; Iain B H Wilson; Vladimir Sladek; Marián Hajdúch; Monika Poláková; Juraj Kóňa
Journal:  ChemMedChem       Date:  2018-02-06       Impact factor: 3.466

7.  Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug design.

Authors:  Lina Irsheid; Thomas Wehler; Christoph Borek; Werner Kiefer; Ruth Brenk; Maria Elena Ortiz-Soto; Jürgen Seibel; Tanja Schirmeister
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.